Christobel Selecky insider trades

Open-market stock purchases and sales by Christobel Selecky, Director at ImmunityBio, Inc, from SEC Form 4 filings since May 3, 2021.

Recent trades

DateStockTradeValue
Jul 1, 2026IBRX ImmunityBio, IncSold$1.4M
Jul 1, 2026IBRX ImmunityBio, IncBought (not open market)—
Jul 1, 2026IBRX ImmunityBio, IncBought (not open market)—
Jun 30, 2026IBRX ImmunityBio, IncSold$9K
Jun 30, 2026IBRX ImmunityBio, IncBought (not open market)—
Jun 30, 2026IBRX ImmunityBio, IncBought (not open market)—
Jun 29, 2026IBRX ImmunityBio, IncSold$862K
Jun 29, 2026IBRX ImmunityBio, IncBought (not open market)—
Jun 29, 2026IBRX ImmunityBio, IncBought (not open market)—
Jun 29, 2026IBRX ImmunityBio, IncBought (not open market)—
Jun 9, 2026IBRX ImmunityBio, IncBought (not open market)—
Feb 23, 2026IBRX ImmunityBio, IncSold$250K
Feb 23, 2026IBRX ImmunityBio, IncBought (not open market)—
Jan 20, 2026IBRX ImmunityBio, IncSold$188K
Jan 20, 2026IBRX ImmunityBio, IncBought (not open market)—
Jan 16, 2026IBRX ImmunityBio, IncSold$250K
Jan 16, 2026IBRX ImmunityBio, IncBought (not open market)—

Companies traded

  • IBRX ImmunityBio, Inc: 6 sales, last Jul 1, 2026

Get free alerts when Christobel Selecky files a new trade →